Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
deals
life sciences
national blog main
san francisco blog main
akouos
astellas pharmaceuticals
biontech
biotech
boehringer ingelheim
boston top stories
california institute for biomedical research
clinical trials
curevac
decibel therapeutics
eli lilly
fda
frequency therapeutics
harvard university
hearing loss
infectious diseases
investing
jeffrey karp
john shiver
moderna therapeutics
mrna
multiple sclerosis
new york blog main
new york top stories
perceptive life sciences
regenerative medicine
robert langer
san francisco top stories
sanofi
sensorineural hearing loss
taiwania capital management
the scripps research institute
translate bio
vaccines
What
date
2
×
medicines
affects
americans
approved
bets
bio
cancer
comes
companies
cut
deal
developing
drug
effective
enticed
evidence
fda
frequency
hasn’t
hearing
ipo
latest
loss
meds
messenger
millions
molecules
mrna
multiple
new
pharmaceutical
plans
primarily
promise
proven
regenerative
rna
sanofi
second
Language
unset
Current search:
date
×
boston
×
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
